Optimize your emergency room flow
suPARnostic® is a prognostic inflammatory biomarker that reflects the level of activation of the human immune system. A low suPAR level indicates a good prognosis and supports the decision to discharge the patient.
A high suPAR level indicates presence, progression and severity of disease, organ damage and risk of mortality, and supports further clinical attention.
This enables you to make your clinical decision based on prognostic evidence.
HEALTHCARE
PROFESSIONAL
MEDICAL
DIRECTOR
CENTRAL
LAB
Read our latest news
suPAR and prediction of Acute Kidney Injury in New England Journal of Medicine
In today’s New England Journal of Medicine, Danish scientists show that patients presenting in the Emergency Department with elevated suPAR (> 4.3 ng/ml, top quartile) have 23 times higher risk [...]
suPAR can predict mild or severe outcome of COVID-19 infection – New study in Critical Care
suPAR is an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. A new study published in Critical Care by Nikoletta Rovina, MD, PhD et al, may be [...]
